Appendicectomy as Adjunctive Therapy in Ulcerative Colitis: Key Considerations
Key Highlights
Medicine · Gastroenterology, Hepatology
New correspondence in The Lancet discusses the COSTA study, which reports that appendicectomy combined with advanced therapy led to higher 12-month clinical remission rates than switching to a JAK inhibitor in patients with moderate-to-severe, biologic-exposed ulcerative colitis. Researchers highlight the pragmatic, real-world design of the trial while noting several methodological features that warrant caution when interpreting the results. For a specialist focused on chronic disease management and complication reduction, this work underscores the potential of surgical adjuncts in autoimmune conditions and invites careful evaluation of emerging treatment paradigms.
Novelty: 78%
Rigor: 85%
Significance: 72%
Validity: 80%
Clarity: 90%
Update Your Briefing Preferences
Stay curious. Stay informed —
Science Briefing
Your briefing is personalized based on your selected fields, keywords, and research interests.
